Search results for: pain

Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

Theodore Pincus, MD | April 1, 2013

Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

ACR/ARHP Annual Meeting 2012: Use a Combination of Tests, Patient History, and Physical Exam when Assessing Myopathies

Susan Bernstein | April 1, 2013

Autoantibody testing, electromyogram, muscle tissue biopsy, and a clinical exam may help confirm a myopathy diagnosis

Tips for Myositis Management

Thomas R. Collins | March 19, 2013

Differentiating between subgroups of myositis is a diagnostic challenge for physicians, but using some guiding principles can be helpful,

Rheuminations: Epigenetics May Help to Explain Why Some Get Rheumatic Disease

Simon M. Helfgott, MD | March 1, 2013

Recent research around genes and environmental stresses suggests outside influences can make lasting changes to the genome via epigenetic mechanisms

The ACR’s Simple Tasks Campaign Expands its Reach, Launches a Blog, and Earns its Fourth Award

Staff | March 1, 2013

Simple Tasks exhibited at the annual meetings of two physician groups, and recently hand-delivered ACR materials to lawmakers on Capitol Hill

What You Need to Know About a Proposed Risk Evaluation and Mitigation Strategy Program for Opioid Analgesics

Staff | March 1, 2013

The U.S. Food and Drug Administration favors enacting a mandatory opioid-prescribing training program for dispensers of the extended-release and long-acting analgesics

ACR/ARHP Annual Meeting 2012: Physicians Search for Ways to Improve Clinical Outcomes for Total Knee Replacements (TKR)

Staff | March 1, 2013

Widely variable results for people post-TKR procedures have prompted doctors to develop a standardized approach to rehabilitation care

ACR/ARHP Annual Meeting 2012: Physicians Find Treatment Options Limited for Scleroderma Bowel Disease

Thomas R. Collins | March 1, 2013

With few proven medical treatments for scleroderma bowel disease, physicians often recommend a lifestyle change for patients as a first treatment option

ACR/ARHP Annual Meeting 2012: What Rheumatologists Need to Know about the New Oral Anticoagulants

Mary Beth Nierengarten | March 1, 2013

A hematologist outlines how the new drugs can help treat coagulation triggered by rheumatological diseases

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | March 1, 2013

Information on new approvals and medication safety that rheumatologists need to know